CytoDyn (CYDY) Share-based Compensation (2010 - 2026)
CytoDyn (CYDY) posted Share-based Compensation of $524,000 for fiscal Q1 2027 (quarter ended Aug 31, 2026), up 192.7% from $179,000 a year earlier but down 36.3% from the prior quarter.
Powered by 
Analysis
CytoDyn (CYDY) Share-based Compensation (2010 - 2026) Analysis & Trends
For the trailing twelve months through Aug 31, 2026, Share-based Compensation at CytoDyn was $1.98 million, up 19.3% year-over-year; for FY2026 (ended May 31, 2026), it was $1.63 million, up 1.1% from FY2025.
- Annual Share-based Compensation shows a five-year compound annual growth rate of -31.0% (FY2021 to FY2026).
- In prior fiscal years, CytoDyn's Share-based Compensation was $1.61 million in FY2025 (-33.3%), $2.42 million in FY2024 (-43.5%), $4.28 million in FY2023 (-31.5%) and $6.24 million in FY2022 (-40.2%).
- Quarterly Share-based Compensation has run from a low of -$438,000 in fiscal Q3 2022 to a high of $2.06 million in fiscal Q2 2022 over five years.
- On a year-over-year basis, Share-based Compensation has increased in each of the last three quarters, with growth averaging 23.4% over the last eight quarters.
- The strongest year-over-year quarter for Share-based Compensation in the past five years was fiscal Q1 2027, with growth of 192.7%; the weakest was fiscal Q1 2025, with a decline of 73.0%.
- According to Business Quant data, Share-based Compensation for the three prior fiscal quarters was $823,000 (Q4 2026), $445,000 (Q3 2026) and $183,000 (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 201.00 Mn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 357.00 Mn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 166.00 Mn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 298.00 Mn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | - |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 165.00 Mn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 231.00 Mn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 249.00 Mn |
| 10 | CytoDyn | 326.90 Mn | 278.05 Mn | - | 524,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Aug 31, 2026 | 524,000.00 |
| May 31, 2026 | 823,000.00 |
| Feb 28, 2026 | 445,000.00 |
| Nov 30, 2025 | 183,000.00 |
| Aug 31, 2025 | 179,000.00 |
| May 31, 2025 | 599,000.00 |
| Feb 28, 2025 | 340,000.00 |
| Nov 30, 2024 | 537,000.00 |
| Aug 31, 2024 | 136,000.00 |
| May 31, 2024 | 471,000.00 |
| Feb 29, 2024 | 869,000.00 |
| Nov 30, 2023 | 572,000.00 |
| Aug 31, 2023 | 503,000.00 |
| May 31, 2023 | 718,000.00 |
| Feb 28, 2023 | 439,000.00 |
| Nov 30, 2022 | 1.78 Mn |
| Aug 31, 2022 | 1.34 Mn |
| May 31, 2022 | 2.02 Mn |
| Feb 28, 2022 | -438,000.00 |
| Nov 30, 2021 | 2.06 Mn |
API Access
CytoDyn Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=CYDY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "CYDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=CYDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();